What is a clinical trial?

A clinical trial is a research study involving human participants designed to evaluate medical interventions — such as drugs, devices, or behavioral strategies. Trials follow a structured protocol and are registered on ClinicalTrials.gov. They progress through phases: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale comparison), and Phase 4 (post-market surveillance).

How do I find clinical trials I'm eligible for?

You can search ClinicalTrials.gov or use ClinicalMetric to filter by condition, phase, or location. Each trial listing includes eligibility criteria such as age range, sex, diagnosis, and prior treatment history. Contact the study team directly or ask your physician to refer you to a relevant trial.

Are clinical trials safe to participate in?

Clinical trials are conducted under strict ethical and regulatory oversight, including IRB approval and FDA regulation in the US. All participants must give informed consent after reviewing potential risks and benefits. Phase 1 trials carry more uncertainty, while Phase 3 trials involve interventions with an established safety profile. Participation is always voluntary and you may withdraw at any time.

What are the phases of clinical trials?

Clinical trials progress through four main phases. Phase 1 tests safety and dosing in a small group (20–80 people). Phase 2 evaluates efficacy and side effects in a larger group (100–300). Phase 3 compares the intervention against standard treatments in thousands of participants. Phase 4 occurs after approval and monitors long-term effects in the general population.

Do participants get paid for joining clinical trials?

Many clinical trials offer compensation for time and travel expenses, though payment structures vary widely by study. Compensation is not intended to be coercive. Some trials also cover treatment costs for participants. Always review the consent form carefully and ask the study coordinator about any financial considerations before enrolling.

Clinical Trial Compensation 2026: How Much Do Trials Pay?

Medical Notice

This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.

Summary

Clinical trial compensation varies widely — from small stipends for outpatient visits to $15,000+ for intensive residential Phase 1 studies. Compensation is designed to reimburse time and inconvenience, not to purchase risk. This guide explains typical payment ranges by trial phase, what compensation covers, tax implications, and how payments are made.

Why Trials Compensate Participants

Compensation in clinical trials serves two purposes: reimbursing participants for out-of-pocket costs (travel, parking, meals, childcare) and providing an "inconvenience payment" for time spent in study visits, procedures, and diaries. Compensation is not intended to be so large that it unduly influences someone to participate against their better judgment — this is an ethical principle reviewed by Institutional Review Boards (IRBs).

Disease trials (where participants are patients seeking treatment) typically offer lower compensation than healthy volunteer trials, since patients may also be receiving a potentially beneficial treatment. Healthy volunteer Phase 1 trials, where there is no anticipated therapeutic benefit, tend to offer the highest compensation.

Compensation by Trial Phase

Phase 1 (healthy volunteers, residential): $3,000–$15,000 per study. These studies require participants to stay at a clinical research unit (CRU) for 3–14 days, receive the drug, and undergo intensive monitoring. Higher compensation reflects the time commitment and the fact that healthy volunteers receive no therapeutic benefit.

Phase 1 (outpatient, patients): $50–$200 per visit. Patient Phase 1 trials are oncology dose-escalation studies; compensation is typically modest because patients may be receiving a potentially beneficial treatment.

Phase 2/3 (outpatient, patients): $25–$150 per visit, plus travel reimbursement. Large Phase 3 trials may have 10–30 visits over 1–3 years; total compensation ranges from $500–$5,000 depending on visit frequency and duration.

Phase 4/observational: $0–$50 per visit. Post-market and registry studies often offer minimal compensation since burden is low and patients may benefit from additional monitoring.

What Compensation Typically Covers

Study drug: Always provided free to participants
Study-related procedures: Lab tests, imaging, ECGs required by the protocol are covered by the sponsor
Travel reimbursement: Most trials reimburse mileage or provide prepaid cards for transportation
Time stipends: Per-visit payments for your time, typically issued after each completed visit

What compensation typically does not cover: adverse event treatment that requires hospitalization (this may be covered separately under the trial's insurance), lost wages, or non-study medical care.

Payment Methods in 2026

Prepaid debit cards (Visa/Mastercard) are the most common payment method, issued after each visit. Digital payments via PayPal, Venmo, or specialized clinical trial payment platforms are increasingly common. Some academic medical center studies pay by check. Residential Phase 1 studies often pay a lump sum at study completion or in installments at discharge.

Tax Considerations

In the United States, clinical trial compensation is taxable income. Sponsors are required to issue a 1099 form if you receive $600 or more in a calendar year (the threshold has been discussed for adjustment). Keep records of all payments received. Travel reimbursements for actual documented expenses are generally not taxable; inconvenience stipends are.

Outside the US, tax treatment varies. In the UK, HMRC has specific guidance on volunteer payments; in the EU, most countries treat trial stipends as income. Consult a tax professional if you participate in multiple trials in a year.

Important Cautions

Ethical guidelines prohibit compensation from being the primary motivator for participation — you should understand and accept the risks independently of payment. If compensation seems exceptionally high relative to the risks described, ask more questions. IRBs review compensation levels to ensure they are not coercive. Healthy volunteer trials at reputable CRUs are generally safe; be wary of trials that are not registered at ClinicalTrials.gov or that cannot be verified.